01 / prediction
You know, if I think that GLP-1s are going to blow up the diet industry, identifying and putting in context a negative result from a human clinical trial, or for example, that adherence rates to Ozempic after a year are just 35%, what are the implications of this?
“You know, if I think that GLP-1s are going to blow up the diet industry, identifying and putting in context a negative result from a human clinical trial, or for example, that adherence rates to Ozempic after a year are just 35%, what are the implications of this?”
- Speaker
- Mike Conover
- Publisher
- Latent Space